{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:48:25Z","timestamp":1781135305894,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05204-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T04:45:56Z","timestamp":1759121156000},"page":"2341-2352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gallbladder neuroendocrine neoplasms: a review"],"prefix":"10.1007","volume":"51","author":[{"given":"Hrishabh","family":"Bhosale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Morani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Virarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"5","key":"5204_CR1","first-page":"3381","volume":"19","author":"C Niu","year":"2020","unstructured":"Niu, C., et al., Neuroendocrine tumors of the gallbladder. Oncol Lett, 2020. 19(5): p. 3381\u20133388.","journal-title":"Oncol Lett"},{"issue":"23","key":"5204_CR2","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.12998\/wjcc.v10.i23.8212","volume":"10","author":"XC Cai","year":"2022","unstructured":"Cai, X.C. and S.D. Wu, Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review. World J Clin Cases, 2022. 10(23): p. 8212\u20138223.","journal-title":"World J Clin Cases"},{"issue":"18","key":"5204_CR3","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao, J.C., et al., One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol, 2008. 26(18): p. 3063\u201372.","journal-title":"J Clin Oncol"},{"issue":"7","key":"5204_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy, A., et al., Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol, 2008. 98(7): p. 485\u20139.","journal-title":"J Surg Oncol"},{"issue":"3","key":"5204_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/1751-2980.13088","volume":"23","author":"W Wang","year":"2022","unstructured":"Wang, W., et al., Clinicopathological characteristics and prognostic factors of patients with primary gallbladder neuroendocrine carcinomas. J Dig Dis, 2022. 23(3): p. 166\u2013173.","journal-title":"J Dig Dis"},{"issue":"14","key":"5204_CR6","doi-asserted-by":"publisher","first-page":"e25449","DOI":"10.1097\/MD.0000000000025449","volume":"100","author":"H Chu","year":"2021","unstructured":"Chu, H., et al., Update in clinical management for gallbladder neuroendocrine carcinoma. Medicine (Baltimore), 2021. 100(14): p. e25449.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"5204_CR7","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1007\/s00330-019-06588-9","volume":"30","author":"JS Bae","year":"2020","unstructured":"Bae, J.S., et al., Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas. Eur Radiol, 2020. 30(5): p. 2890\u20132901.","journal-title":"Eur Radiol"},{"key":"5204_CR8","doi-asserted-by":"publisher","first-page":"5592525","DOI":"10.1155\/2021\/5592525","volume":"2021","author":"P Wang","year":"2021","unstructured":"Wang P et al (2021) Neuroendocrine Neoplasms of the Gallbladder: A Clinicopathological Analysis of 13 Patients and a Review of the Literature. Gastroenterol Res Pract 2021:5592525","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"5204_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal, I.D., et al., The 2019 WHO classification of tumours of the digestive system. Histopathology, 2020. 76(2): p. 182\u2013188.","journal-title":"Histopathology"},{"issue":"1","key":"5204_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi, G., et al., Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol, 2022. 33(1): p. 115\u2013154.","journal-title":"Endocr Pathol"},{"issue":"9","key":"5204_CR11","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","volume":"40","author":"LH Tang","year":"2016","unstructured":"Tang, L.H., et al., A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Am J Surg Pathol, 2016. 40(9): p. 1192\u2013202.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"5204_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.5858\/arpa.2019-0665-RA","volume":"145","author":"N Assarzadegan","year":"2021","unstructured":"Assarzadegan, N. and E. Montgomery, What is new in the 2019 World Health Organization (WHO) classification of tumors of the digestive system: review of selected updates on neuroendocrine neoplasms, appendiceal tumors, and molecular testing. Archives of pathology & laboratory medicine, 2021. 145(6): p. 664\u2013677.","journal-title":"Archives of pathology & laboratory medicine"},{"key":"5204_CR13","doi-asserted-by":"crossref","unstructured":"Gheorghi\u0219an-G\u0103l\u0103\u021beanu, A.A., et al., The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications. Int J Mol Sci, 2023. 24(2).","DOI":"10.3390\/ijms24021418"},{"issue":"12","key":"5204_CR14","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1245\/s10434-022-12107-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang, Y., et al., Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade. Ann Surg Oncol, 2022. 29(12): p. 7619\u20137630.","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 2","key":"5204_CR15","first-page":"S95-9","volume":"12","author":"P Tomassetti","year":"2001","unstructured":"Tomassetti, P., et al., Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol, 2001. 12 Suppl 2: p. S95-9.","journal-title":"Ann Oncol"},{"issue":"6","key":"5204_CR16","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1007\/s00464-017-5952-8","volume":"32","author":"S Kim","year":"2018","unstructured":"Kim, S., et al., Laparoscopic extended cholecystectomy for T3 gallbladder cancer. Surg Endosc, 2018. 32(6): p. 2984\u20132985.","journal-title":"Surg Endosc"},{"issue":"5","key":"5204_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/RCT.0000000000000753","volume":"42","author":"SA Faraoun","year":"2018","unstructured":"Faraoun, S.A., et al., Computed Tomographic Features of Primary Small Cell Neuroendocrine Tumors of the Gallbladder. J Comput Assist Tomogr, 2018. 42(5): p. 707\u2013713.","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"5204_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/cancers13030547","volume":"13","author":"D Giannis","year":"2021","unstructured":"Giannis, D., et al., Validation of the 8th Edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors. Cancers, 2021. 13(3): p. 547.","journal-title":"Cancers"},{"issue":"4","key":"5204_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejso.2019.10.015","volume":"46","author":"J Wang","year":"2020","unstructured":"Wang, J., et al., Modified staging classification of gallbladder carcinoma on the basis of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system. European Journal of Surgical Oncology, 2020. 46(4): p. 527\u2013533.","journal-title":"European Journal of Surgical Oncology"},{"key":"5204_CR20","doi-asserted-by":"publisher","first-page":"1183619","DOI":"10.3389\/fphar.2023.1183619","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y., et al., Gallbladder cancer: current and future treatment options. Front Pharmacol, 2023. 14: p. 1183619.","journal-title":"Front Pharmacol"},{"issue":"6","key":"5204_CR21","doi-asserted-by":"publisher","first-page":"e468-e469","DOI":"10.1097\/RLU.0000000000004157","volume":"47","author":"R Solanki","year":"2022","unstructured":"Solanki, R., H. Singh, and R. Kumar, Exceptional Visualization of the Gallbladder on 68Ga-DOTANOC PET\/CT Imaging. Clin Nucl Med, 2022. 47(6): p. e468-e469.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"5204_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2967\/jnumed.113.126896","volume":"55","author":"A Imperiale","year":"2014","unstructured":"Imperiale, A., et al., 18F-fluorodihydroxyphenylalanine PET\/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. J Nucl Med, 2014. 55(3): p. 367\u201372.","journal-title":"J Nucl Med"},{"issue":"2","key":"5204_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5387\/fms.2017-04","volume":"63","author":"M Sugimoto","year":"2017","unstructured":"Sugimoto, M., et al., Contrast-enhanced harmonic endoscopic ultrasonography in gallbladder cancer and pancreatic cancer. Fukushima J Med Sci, 2017. 63(2): p. 39\u201345.","journal-title":"Fukushima J Med Sci"},{"issue":"2","key":"5204_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00330-016-4394-3","volume":"27","author":"TH Kim","year":"2017","unstructured":"Kim, T.H., et al., Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas. Eur Radiol, 2017. 27(2): p. 507\u2013517.","journal-title":"Eur Radiol"},{"issue":"12","key":"5204_CR25","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1007\/s00261-022-03713-z","volume":"47","author":"S Martin","year":"2022","unstructured":"Martin, S., et al., Neuroendocrine neoplasm imaging: protocols by site of origin. Abdominal Radiology, 2022. 47(12): p. 4081\u20134095.","journal-title":"Abdominal Radiology"},{"key":"5204_CR26","volume-title":"Molecular imaging theranostics of neuroendocrine tumors. in Seminars in nuclear medicine","author":"E Fortunati","year":"2023","unstructured":"Fortunati E et al (2023) Molecular imaging theranostics of neuroendocrine tumors. in Seminars in nuclear medicine. Elsevier"},{"key":"5204_CR27","doi-asserted-by":"crossref","unstructured":"Kaewput, C. and S. Vinjamuri, Role of Combined (68)Ga DOTA-Peptides and (18)F FDG PET\/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics (Basel), 2022. 12(2).","DOI":"10.3390\/diagnostics12020280"},{"issue":"2","key":"5204_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cpet.2022.11.001","volume":"18","author":"A Kandathil","year":"2023","unstructured":"Kandathil, A. and R.M. Subramaniam, Gastroenteropancreatic neuroendocrine tumor diagnosis: DOTATATE PET\/CT. PET clinics, 2023. 18(2): p. 189\u2013200.","journal-title":"PET clinics"},{"issue":"2","key":"5204_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2214\/AJR.18.19881","volume":"211","author":"Y Sanli","year":"2018","unstructured":"Sanli, Y., et al., Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET\/CT. American Journal of Roentgenology, 2018. 211(2): p. 267\u2013277.","journal-title":"American Journal of Roentgenology"},{"issue":"5","key":"5204_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2214\/AJR.21.27159","volume":"218","author":"SJ Galgano","year":"2022","unstructured":"Galgano, S.J., et al., Imaging of neuroendocrine neoplasms: monitoring treatment response\u2014AJR Expert Panel Narrative Review. American Journal of Roentgenology, 2022. 218(5): p. 767\u2013780.","journal-title":"American Journal of Roentgenology"},{"issue":"6","key":"5204_CR31","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.17305\/bb.2023.9582","volume":"23","author":"YF Hu","year":"2023","unstructured":"Hu, Y.F., et al., Comparison of the clinical features and long-term prognosis of gallbladder neuroendocrine carcinoma versus gallbladder adenocarcinoma: A propensity score-matched analysis. Biomol Biomed, 2023. 23(6): p. 1096\u20131107.","journal-title":"Biomol Biomed"},{"issue":"1","key":"5204_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12893-022-01689-7","volume":"22","author":"BH Zheng","year":"2022","unstructured":"Zheng, B.H., et al., The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database. BMC Surg, 2022. 22(1): p. 253.","journal-title":"BMC Surg"},{"issue":"3","key":"5204_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/cam4.4463","volume":"11","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., et al., Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder. Cancer Med, 2022. 11(3): p. 641\u2013653.","journal-title":"Cancer Med"},{"issue":"6","key":"5204_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jso.27600","volume":"129","author":"K Nandy","year":"2024","unstructured":"Nandy, K., et al., Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors. J Surg Oncol, 2024. 129(6): p. 1121\u20131130.","journal-title":"J Surg Oncol"},{"issue":"1","key":"5204_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00423-021-02256-z","volume":"407","author":"S Gogna","year":"2022","unstructured":"Gogna, S., et al., Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome. Langenbecks Arch Surg, 2022. 407(1): p. 197\u2013206.","journal-title":"Langenbecks Arch Surg"},{"issue":"47","key":"5204_CR36","doi-asserted-by":"publisher","first-page":"e8778","DOI":"10.1097\/MD.0000000000008778","volume":"96","author":"W Liu","year":"2017","unstructured":"Liu, W., et al., Cholecystectomy with gallbladder bed cautery might be sufficient for T1bN0M0 neuroendocrine carcinoma of gallbladders: Cases report and literature review. Medicine (Baltimore), 2017. 96(47): p. e8778.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5204_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12957-024-03436-z","volume":"22","author":"F Liu","year":"2024","unstructured":"Liu, F., et al., Clinical diagnosis and treatment of 37 cases of gallbladder neuroendocrine carcinoma. World J Surg Oncol, 2024. 22(1): p. 157.","journal-title":"World J Surg Oncol"},{"issue":"10","key":"5204_CR38","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/PAS.0000000000001536","volume":"44","author":"SM Lee","year":"2020","unstructured":"Lee, S.M. and C.O. Sung, Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic and Immunohistochemical Analysis of 34 Resected Cases. Am J Surg Pathol, 2020. 44(10): p. 1308\u20131321.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"5204_CR39","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1177\/0003134820951466","volume":"88","author":"A Sharma","year":"2022","unstructured":"Sharma, A., et al., Neuroendocrine Carcinoma of the Gallbladder. Am Surg, 2022. 88(11): p. 2768\u20132770.","journal-title":"Am Surg"},{"issue":"1","key":"5204_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40001-019-0363-z","volume":"24","author":"W Liu","year":"2019","unstructured":"Liu, W., et al., Neuroendocrine carcinoma of gallbladder: a case series and literature review. Eur J Med Res, 2019. 24(1): p. 8.","journal-title":"Eur J Med Res"},{"issue":"2","key":"5204_CR41","doi-asserted-by":"publisher","first-page":"e19-e20","DOI":"10.1097\/MPA.0000000000001480","volume":"49","author":"J Chorath","year":"2020","unstructured":"Chorath, J., et al., Durable response to carboplatin, etoposide, nivolumab, and ipilimumab in metastatic high-grade neuroendocrine carcinoma of the gallbladder. Pancreas, 2020. 49(2): p. e19-e20.","journal-title":"Pancreas"},{"issue":"5","key":"5204_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000534747","volume":"102","author":"H Imai","year":"2024","unstructured":"Imai, H., et al., Comparison of Efficacy and Safety between Carboplatin-Etoposide and Cisplatin-Etoposide Combination Therapy in Patients with Advanced Neuroendocrine Carcinoma: A Retrospective Study. Oncology, 2024. 102(5): p. 359\u2013367.","journal-title":"Oncology"},{"issue":"2","key":"5204_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12029-018-0070-y","volume":"50","author":"AV Kanetkar","year":"2019","unstructured":"Kanetkar, A.V., et al., Neuroendocrine carcinoma of gallbladder: a step beyond palliative therapy, experience of 25 cases. Journal of Gastrointestinal Cancer, 2019. 50(2): p. 298\u2013303.","journal-title":"Journal of Gastrointestinal Cancer"},{"issue":"6","key":"5204_CR44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/jpm13061009","volume":"13","author":"J Khan","year":"2023","unstructured":"Khan, J., et al., Comparative survival benefits of surgery and adjuvant chemotherapy in neuroendocrine carcinoma of the gallbladder: a population-based study with insight into future personalized therapeutic approach. Journal of Personalized Medicine, 2023. 13(6): p. 1009.","journal-title":"Journal of Personalized Medicine"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05204-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:04:16Z","timestamp":1775653456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05204-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5204"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05204-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}